Cancer Institute of New Jersey SC — New Brunswick, New Jersey

Cancer Institute of New Jersey SC is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Institute of New Jersey SC has participated in 1 clinical trials.

Therapeutic areas: Castration-resistant Prostate Cancer, Metastatic Breast Cancer, Uterine Leiomyoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Institute of New Jersey SC?

Cancer Institute of New Jersey SC has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Institute of New Jersey SC conducted?

Cancer Institute of New Jersey SC has 1 clinical trials on record. Their work covers Castration-resistant Prostate Cancer, Metastatic Breast Cancer, Uterine Leiomyoma.

Is Cancer Institute of New Jersey SC accredited by Crixeo Health?

Cancer Institute of New Jersey SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Institute of New Jersey SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.